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SUMMARY. The aim of this study was to evaluate the influence of socio-economic, clinical and pharma-
cotherapeutic determinants, adherence to therapy on the quality of life and glycemic control in patients
with type 2 diabetes mellitus. We conducted a cross-sectional study exploratory. Data collection was con-
ducted through structured interviews and analysis of medical records. We interviewed 146 adult patients.
Increasing age, body mass index, number of antidiabetic medications used and blacks, were related to
higher levels of glycated hemoglobin. The results indicate that glycemic control was negatively influenced
by non-adherence to drug treatment and a higher complexity of pharmacotherapy was related to noncom-
pliance. Health-Related Quality of life (HRQOL) as assessed by the Nottingham Health Profile has nega-
tive influence of diabetes complications. HRQOL, as assessed by the Diabetes Quality of Life (DQOL), was
negatively affected by poor glycemic control.
